Arthur J. Moss, MD
March 30th, 2014
Long-Term Follow-Up from MADIT-CRT: Guideline Implications
Arthur J. Moss, MD
Arthur J. Moss discusses his research group’s study of long-term survival for patients who received cardiac resynchronization therapy with a defibrillator in the MADIT-CRT trial.
November 6th, 2012
A New Era in ICD Therapy — Get with the Programming!
Arthur J. Moss, MD
The principal investigator of the MADIT-RIT trial comments on the clinical implications of his study group’s research.
November 14th, 2010
A Life-RAFT for Patients with HF?
Arthur J. Moss, MD
CardioExchange welcomes Arthur Moss, Professor of Medicine at the University of Rochester School of Medicine and lead investigator of the MADIT-CRT trial, to discuss his New England Journal of Medicine editorial on the RAFT trial, in which patients with mild-to-moderate HF were randomized to receive either an ICD alone or ICD plus CRT. It seems […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy